Alignment Healthcare, Inc. (ALHC)Chief Medical Officer sold ~$224K
Hyong Kim, Chief Medical Officer at Alignment Healthcare, Inc., sold ~$224K of Alignment Healthcare, Inc. shares.
- ~$224K
- Approx. value · 12K sh @ $18.71
- 350K
- Holds after · shares reported
- Traded
- Dec 29, 2025
- Filed
- Dec 31, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 10, 2025InsiderCEO sold ~$2.94M of ALHC shares in the open market
- Nov 11, 2025InsiderDirector sold ~$80K of ALHC shares in the open market
- Nov 25, 2025InsiderDirector sold ~$475K of ALHC shares in the open market
- Dec 8, 2025InsiderOfficer sold ~$381K of ALHC shares in the open market
- Dec 10, 2025Insider · 2 peopleInsiders: 2 sales (~$3.7M)
- Dec 12, 2025Insider · 3 peopleInsiders: 3 sales (~$413.3M)
- Dec 15, 2025InsiderOfficer sold ~$2.27M of ALHC shares in the open market
- Dec 29, 2025 · this disclosureInsiderOfficer sold ~$224K of ALHC shares in the open market
What came next
- Dec 29, 2025Insider · 5 peopleInsiders: 9 sales (~$18.3M)
- Jan 2, 2026Insider · 2 peopleInsiders: 2 sales (~$2.2M)
- Jan 6, 2026Insider · 2 peopleInsiders: 2 sales (~$5.2M)
- Jan 12, 2026Insider · 1 personInsiders: 2 sales (~$3.8M)
- Jan 15, 2026Insider · 1 personInsiders: 2 sales (~$674K)
- Feb 10, 2026Insider · 2 peopleInsiders: 2 sales (~$4.1M)
- Feb 17, 2026InsiderOfficer sold ~$619K of ALHC shares in the open market
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 2, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Mar 4, 2026InsiderOfficer sold ~$393K of ALHC shares in the open market
- Mar 10, 2026InsiderCEO sold ~$3.27M of ALHC shares in the open market
- Mar 12, 2026Insider · 3 peopleInsiders: 6 sales (~$1.4M)
- Mar 16, 2026InsiderOfficer sold ~$524K of ALHC shares in the open market
- Mar 18, 2026Insider · 7 peopleInsiders: 7 sales (~$3.4M)
- Mar 19, 2026InsiderOfficer sold ~$211K of ALHC shares in the open market
- Mar 23, 2026InsiderCEO sold ~$2.06M of ALHC shares in the open market
- Apr 1, 2026InsiderOfficer sold ~$320K of ALHC shares in the open market
- Apr 7, 2026Insider · 2 peopleInsiders: 3 sales (~$5.5M)
- Apr 10, 2026Insider · 1 personInsiders: 2 sales (~$4.5M)
- Apr 13, 2026InsiderCEO sold ~$1.71M of ALHC shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Alignment Healthcare, Inc.
For Alignment Healthcare, Inc., OQRO holds 12 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALHC page.
Other recent filings by Hyong Kim, Chief Medical Officer
- SEC Form 4 at Alignment Healthcare, Inc. (ALHC)Oct 8, 2026
- SEC Form 4 at Alignment Healthcare, Inc. (ALHC)Jun 16, 2026
- SEC Form 4 at Alignment Healthcare, Inc. (ALHC)Mar 20, 2026
- SEC Form 4 at Alignment Healthcare, Inc. (ALHC)Jan 7, 2026
- SEC Form 4 at Alignment Healthcare, Inc. (ALHC)Dec 31, 2025
The full history of Hyong Kim, Chief Medical Officer is on the profile page.
How this filing works
Other disclosures at Alignment Healthcare, Inc.
- SEC Form 4Oct 8, 2026
- SEC Form 144Oct 5, 2026
- SEC Form 4Sep 19, 2026
- SEC Form 4Sep 17, 2026
- SEC Form 4Sep 12, 2026
- SEC Form 4Sep 12, 2026
Everything OQRO holds on this company is on its ALHC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
